how the management of cll is evolving
Published 8 years ago • 906 plays • Length 3:29Download video MP4
Download video MP3
Similar videos
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19
-
1:00
identifying new cll therapeutic targets by focusing on the evolution of cancer cells
-
1:04
defining high-risk cll: known and emerging mutations
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
0:45
key trials in cll and designing a concept for treatment
-
5:28
chronic lymphocytic leukemia (cll) and your genes
-
3:13
cll versus other leukemia types
-
21:06
lymphoid series part 1
-
2:19
long-term management of cll for improved outcomes
-
1:19
cll treatment: a look into the future
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
6:17
the progression and evolution of cll: mechanisms and therapies
-
0:53
all-cll: an ngs panel for molecular characterization of cll
-
1:49
the future of cll: managing new toxicities and improved categorization
-
1:09
cll treatment: discussing new data from the last 3 years
-
2:49
assessing parameters and standardising biomarker detection in cll
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
2:02
key questions about the future of cll
-
3:55
the origins of mutated and unmutated cll
-
0:34
advice for community physicians managing richter's transformation of cll
-
2:29
the measurement of molecular biomarkers to aid cll treatment